Skip to content

Acupoint catgut embedding combined with hormone replacement therapy in the treatment of diminished ovarian reserve: A randomized controlled study

Acupoint catgut embedding combined with hormone replacement therapy in the treatment of diminished ovarian reserve: A randomized controlled study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003762
Enrollment
Unknown
Registered
2020-08-27
Start date
2020-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diminished ovarian reserve

Interventions

Sponsors

Shanghai Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of traditional Chinese and Western medicine for ovarian reserve hypofunction; 2. Female patients 18 years old and younger than 40 years old; 3. Those who have signed an informed consent and can cooperate to complete the planned course of treatment;

Exclusion criteria

Exclusion criteria: 1. Severe Kupperman syndrome score; 2. Patients with premature ovarian failure caused by drugs such as hormones and immunosuppressants; 3. Premature ovarian failure caused by bilateral or unilateral ovarian resection; 4. Combined with organic diseases of reproductive organs; 5. Patients with severe primary diseases such as cardiovascular, liver, kidney and hematopoietic system, and mental illness.

Design outcomes

Primary

MeasureTime frame
Serum sex hormone levels;

Secondary

MeasureTime frame
Medical Outcomes Survey Short Form-36 (SF-36);Hamilton Rating Scale for Anxiety;Menstrual Condition Score Form;Antral follicle count;Kupperman Scale;Hamilton Rating Scale for Depression;

Countries

China

Contacts

Public ContactQi Jin

Shanghai Traditional Chinese Medicine Hospital

jessyqi0606@163.com+86 13122208396

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026